February 4, 2021
JAMA Oncology

Why Not Adore ADAURA?—The Trial We Need vs the Trial We Got

AccessHope’s Executive Medical Director, Jack West, MD, shares his perspective on lung cancer treatment advancements and the recent results of the ADAURA trial in a Viewpoint for JAMA Oncology. In this piece, Dr. West emphasizes the importance of the knowledge uncovered, comments on the benefits and pitfalls of the trial, and highlights the continued work that must be done by the oncological community to optimize patient outcomes.
 

Read Full Article Here

Previous

Get started with AccessHope today

AccessHope’s team of specialists is ready to help plan the best suite of cancer support services for your employees.

Get started